Ara Parseghian Medical Research Foundation

Join us in the Fight Against Niemann-Pick Type C Disease

Newsletter

Newsletters & Videos


"A Goal For Life"

The Ara Parseghian Medical Research Foundation Newsletter

-----
Donate Now

We invite you to read our newsletter, "A Goal For Life", which provides quick and easy access to information about what's new at Ara Parseghian Medical Research Foundation, research updates, fundraising stories and features about NP-C patients and families.

To the left, you can view videos that include messages from Cindy Parseghian and an interview with Ara Parseghian.

----------

Winter 2009 Newsletter

Heartfelt Thanks

The Notre Dame Club of Milwaukee hosted the ninth annual “Ara’s Outing 2009” in Brookfi eld, WI this past July. More than a dozen from “The Era” travelled to Milwaukee to honor Ara. 150 alumni and friends – including 13 Irish football players from the period of 1964- 74 – joined in the festivities at the beautiful Westmoor Country Club on Monday, July 13 to raise money for the Ara Parseghian Medical Research Foundation (APMRF). Standing in for the Hall of Fame coach who was unable to attend, alumna and daughter-in-law, Cindy Parseghian, the APMRF’s president, thanked the attendees for the Club’s nine years worth of contributions, saying that it has accounted for more than $150,000 toward research to fi nd a cure for NP-C.

Read More

----------

Summer 2009 Newsletter

NP-C Annual Scientific Conference

In June, eighty researchers from around the world convened a meeting to discuss the advances in Niemann-Pick Type C (NP-C) disease research. These meetings were funded by generous grants from the Bacon Family Foundation and the C. R. Bard Foundation, Inc. In addition to the research presentations spanning
two and half days, a full day was also devoted to the fi rst ever clinical workshop cosponsored by the National Institutes of Health.
A summary of the presentations is provided inside this newsletter.

Read More

----------

Spring 2009 Newsletter

Zavesca Approved in Europe

The APMRF has been intimately involved in helping to fund and speed development of the drug Zavesca, which led to a clinical drug trial. We are very excited to announce that Zavesca has been approved for treatment of patients with NP-C disease in Europe. Our hope is that the Food and Drug Administration
(FDA) in the US will soon follow the lead of their European counterpart and approve the drug for US patients.

Through funding provided by the Parseghian Foundation, Dr. Steven Walkley of Albert Einstein College of Medicine in Bronx, NY administered Zavesca to NP-C mice. He found a positive affect and after a number of years, this led
to the first-ever clinical trial with NP-C patients.

Read More

----------

   

---
© 2008 Ara Parseghian Medical Research Foundation
3530 E. Campo Abierto, Suite 105, Tucson, Arizona 85718-3327, Phone: (520) 577-5106 Fax: (520) 577-5212, E-Mail: victory@parseghian.org